Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, China

Oncology

Volumn 76, Issue 3, 2009, Pages 157-161

  Cai, Hong Bing ^a   Ding, Xiao Hua ^b   Chen, Chang Chun ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus; Polymerase chain reaction

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGED; CHINA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; PRECANCEROUS CONDITIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 58649090435     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000195885     Document Type: Article

References (24)

1. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):4-66.
2. Li L, Lu F, Zhang S: Cancer mortality trends in the People's Republic of China: 1973-1992. Chin J Oncol 1997;19:3-9.
3. Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, et al: Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 1999;30:240-250.
4. Clifford GM, Smith JS, Plummer M, et al: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:36-73.
5. Munoz N, Bosch FX, Bosch FX, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
6. Chichareon S, Herrero R, Munoz N, et al: Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-57.
7. Bosch F, Manos M, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
8. IARC. Epideminology of infection. IARC monographs on the evaluation of carcinogenic risks to humans; in Human Papillomavirus Viruses. Lyon, International Agency Research on Cancer, 1995, vol 64, pp 96-102.
9. Lo K, Wong TF, Chan MK, et al: Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer 2002;100:327-331.
10. Liu J, Rose B, Huang X, et al: Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 2004;94:803-810.
11. Wu Y, Chen Y, Li L, et al: Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006;35:264-269.
12. Breitburd F, Coursaget P: Human papillomavirus vaccines. Semin Cancer Biol 1999;9:431-444.
13. Villa LL, Sichero L, Rahal P, et al: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-2968.
14. Sowjanya AP, Jain M, Poli UR, et al: Prevalence and distribution of high-risk human papillomavirus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005;5:116 (http://www.biomedcentral.com/1471-23345/116/prepub).
15. Huang S, Afonina I, Miller BA, et al: Human papillomavirus types 52 and 58 are prevalent in cervical infection in young women. Int J Cancer 1997;70:408-411.
16. Lai HC, Sun CA, Yu MH, et al: Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related type. Int J Cancer 1999;84:553-557.
17. Hwang TS, Jeong JK, Park M, et al: Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003;90:51-55.
18. Cho NH, An HJ, Jeong JK, et al: Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 2003;188:56-62.
19. Franceschi S, Rajkumar T, Vaccarella S, et al: Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003;107:127-133.
20. Chen CA, Liu CY, Chou HH, et al: The distribution and differential risk of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. Int J Cancer 2006;16:1801-1808.
21. Lee SA, Kang D, Seo SS, et al: Multiple HPV infection in cervical cancer screened by HPV DNA chip. Cancer Lett 2003;198:182-192.
22. Ho GY, Bierman R, Beardley L, et al: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428.
23. Liaw KL, Hildesheim A, Burk RD: A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001;183:8-15.
24. Rousseau MC, Pereira JS, Prado JC, et al: Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001;184:1508-1517.